Volume Spike Investor

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has already come close to 2-times normal trading volume after a brokerage firm downgrade.  This also follows a large downward move from last week.   You can read the full details at BioHealthInvestor.com to see the fundamental reasoning.

We have also seen some options trading in the near month(s) contracts, although the action looks more in the stock than in options today.  Amylin has seen over 4.4 million shares trade by 11:40 AM EST and shares are down over 9% to $27.18.  Its 52-week trading range is $23.75 to $53.25.

Jon Ogg
June 9, 2008